186 related articles for article (PubMed ID: 27088717)
1. Prenyl Ammonium Salts--New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model.
Grecka E; Statkiewicz M; Gorska A; Biernacka M; Grygorowicz MA; Masnyk M; Chmielewski M; Gawarecka K; Chojnacki T; Swiezewska E; Malecki M
PLoS One; 2016; 11(4):e0153633. PubMed ID: 27088717
[TBL] [Abstract][Full Text] [Related]
2. Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets.
Markov OO; Mironova NL; Maslov MA; Petukhov IA; Morozova NG; Vlassov VV; Zenkova MA
J Control Release; 2012 Jun; 160(2):200-10. PubMed ID: 22155599
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
Zhang B; Zhang Y; Yu D
Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
[TBL] [Abstract][Full Text] [Related]
4. Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model.
Markov OV; Mironova NL; Shmendel EV; Serikov RN; Morozova NG; Maslov MA; Vlassov VV; Zenkova MA
J Control Release; 2015 Sep; 213():45-56. PubMed ID: 26134071
[TBL] [Abstract][Full Text] [Related]
5. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
6. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J
Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882
[TBL] [Abstract][Full Text] [Related]
7. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
8. Chondroitin sulfate capsule system for efficient and secure gene delivery.
Kurosaki T; Kitahara T; Fumoto S; Nishida K; Yamamoto K; Nakagawa H; Kodama Y; Higuchi N; Nakamura T; Sasaki H
J Pharm Pharm Sci; 2010; 13(3):351-61. PubMed ID: 21092708
[TBL] [Abstract][Full Text] [Related]
9. Introduction of murine Il-4 gene into B16(F10) melanoma tumors by direct gene transfer with DNA-liposome complexes.
Missol E; Sochanik A; Szala S
Cancer Lett; 1995 Nov; 97(2):189-93. PubMed ID: 7497462
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo transfection of melanoma cells B16-F10 mediated by cholesterol-based cationic liposomes.
Reynier P; Briane D; Cao A; Lievre N; Naejus R; Bissieres P; Salzmann JL; Taillandier E
J Drug Target; 2002 Nov; 10(7):557-66. PubMed ID: 12683723
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by tyroserleutide (YSL) on the invasion and adhesion of the mouse melanoma cell.
Yao Z; Che XC; Lu R; Zheng MN; Zhu ZF; Li JP; Jian X; Shi LX; Liu JY; Gao WY
Mol Med; 2007; 13(1-2):14-21. PubMed ID: 17515953
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of B16 melanoma cells genetically modified with the angiogenesis inhibitor rnasin.
Botella-Estrada R; Malet G; Revert F; Dasí F; Crespo A; Sanmartín O; Guillén C; Aliño SF
Cancer Gene Ther; 2001 Apr; 8(4):278-84. PubMed ID: 11393280
[TBL] [Abstract][Full Text] [Related]
13. Sticky siRNAs targeting survivin and cyclin B1 exert an antitumoral effect on melanoma subcutaneous xenografts and lung metastases.
Kedinger V; Meulle A; Zounib O; Bonnet ME; Gossart JB; Benoit E; Messmer M; Shankaranarayanan P; Behr JP; Erbacher P; Bolcato-Bellemin AL
BMC Cancer; 2013 Jul; 13():338. PubMed ID: 23835136
[TBL] [Abstract][Full Text] [Related]
14. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions.
Anwer K; Kao G; Proctor B; Rolland A; Sullivan S
J Drug Target; 2000; 8(2):125-35. PubMed ID: 10852344
[TBL] [Abstract][Full Text] [Related]
15. Serum-resistant complex nanoparticles functionalized with imidazole-rich polypeptide for gene delivery to pulmonary metastatic melanoma.
Gu J; Chen X; Xin H; Fang X; Sha X
Int J Pharm; 2014 Jan; 461(1-2):559-69. PubMed ID: 24370843
[TBL] [Abstract][Full Text] [Related]
16. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
[TBL] [Abstract][Full Text] [Related]
17. [Antitumoral efficacy by systemic delivery of cationic liposome-plasmid interleukin-15 complexes in murine models of lung metastasis].
Teng X; Zhou XK; Zhang YB; Qiu J; Mao YQ; Deng HX; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):148-52. PubMed ID: 22304773
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.
Ishiguro T; Nakajima M; Naito M; Muto T; Tsuruo T
Cancer Res; 1996 Feb; 56(4):875-9. PubMed ID: 8631027
[TBL] [Abstract][Full Text] [Related]
19. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
Lucas ML; Heller L; Coppola D; Heller R
Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
[TBL] [Abstract][Full Text] [Related]
20. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
Yei S; Bartholomew RM; Pezzoli P; Gutierrez A; Gouveia E; Bassett D; Soo Hoo W; Carlo DJ
Gene Ther; 2002 Oct; 9(19):1302-11. PubMed ID: 12224013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
